
Glimfirst MP 1mg/500mg/15mg Tablet
Marketer
Sinsan Pharmaceuticals
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimfirst MP 1mg/500mg/15mg Tablet
Metformin-Pioglitazone-Glimepiride 1mg/500mg/15mg tablets offer a combined approach to managing blood glucose. This medication, used alongside a healthy diet and regular exercise, enhances blood sugar regulation in adult patients with type 2 diabetes. It facilitates efficient insulin use, consequently reducing blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Ingestion with food is recommended to mitigate potential stomach discomfort. Should you miss a dose, take it promptly; however, if your next dose is imminent, omit the missed dose and resume your normal schedule. Never double the dose. Excessive intake can result in hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Kidney function tests will be evaluated by your doctor before initiating therapy. Limit alcohol consumption as it may exacerbate side effects.
Uses of Glimfirst MP 1mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimfirst MP 1mg/500mg/15mg Tablet:
Follow your physician's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimfirst MP 1mg/500mg/15mg Tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.
Common Side effects of Glimfirst MP 1mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimfirst MP 1mg/500mg/15mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Glimfirst MP 1mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
How Glimfirst MP 1mg/500mg/15mg Tablet works:
Glimfirst MP tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions—to enhance blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimfirst MP 1mg/500mg/15mg Tablet with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Glimfirst MP 1mg/500mg/15mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimfirst MP 1mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimfirst MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Medical consultation is necessary. This medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimfirst MP 1mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glimfirst MP 1mg/500mg/15mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Glimfirst MP 1mg/500mg/15mg Tablet :
Should you forget to take a Glimfirst MP 1mg/500mg/15mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Glimfirst MP 1mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
